TGF-β upregulates the translation of USP15 via the PI3K/AKT pathway to promote p53 stability
2016 · Oncogene · 84 citations
https://doi.org/10.1038/onc.2016.424
H
Haochen Yu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
81
Papers
1.6K
Citations
19
h-index
30
i10-index
Haochen Yu is an academic researcher from St. Michael's Hospital. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Catalytic Processes in Materials Science & Ferroptosis and cancer prognosis. The author has an h-index of 19, co-authored 69 publications.
ORCID: 0000-0002-8356-1828Papers by this author
worksLow pretreatment lymphocyte/monocyte ratio is associated with the better efficacy of neoadjuvant chemotherapy in breast cancer patients
2019 · Cancer Biology & Therapy · 40 citations
https://doi.org/10.1080/15384047.2019.1680057
A ferroptosis-associated gene signature for the prediction of prognosis and therapeutic response in luminal-type breast carcinoma
2021 · Scientific Reports · 26 citations
https://doi.org/10.1038/s41598-021-97102-z
Tigecycline causes loss of cell viability mediated by mitochondrial OXPHOS and RAC1 in hepatocellular carcinoma cells
2023 · Journal of Translational Medicine · 17 citations
https://doi.org/10.1186/s12967-023-04615-4
A novel immune-related gene signature predicting survival in sarcoma patients
2021 · Molecular Therapy — Oncolytics · 12 citations
https://doi.org/10.1016/j.omto.2021.12.007
SMAD4 depletion contributes to endocrine resistance by integrating ER and ERBB signaling in HR + HER2− breast cancer
2024 · Cell Death and Disease · 10 citations
https://doi.org/10.1038/s41419-024-06838-9
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat